Journals / Klinik Psikofarmakoloji Bülteni / 2014 / Cilt: 24 - Sayı: 4

İki uçlu bozukluğu olan bir hastada valporik asit nedenli perikardiyal ve plevral efüzyon

Pericardial and pleural effusion with valproic acid use in a patient with bipolar disorder

Pages
387–390
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

To the best of our knowledge, the presented case is the first to report the concurrent development of exudative pericardial and pleural effusion arising from the use of valproic acid.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Valproic acid is a widely used drug in various medical situations and settings.
📊
Key Findings & Data:The occurrence of pleural effusion due to the use of valproic acid is very rarely encountered.
💡
Conclusion & Impact:To the best of our knowledge, the presented case is the first to report the concurrent development of exudative pericardial and pleural effusion arising from the use of valproic acid.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Valproic acid is a widely used drug in various medical situations and settings. The occurrence of pleural effusion due to the use of valproic acid is very rarely encountered. Here, we present a case diagnosed with bipolar disorder, who had used valproic acid for a year. Pericardial and pleural effusion was determined in the case during the treatment. To the best of our knowledge, the presented case is the first to report the concurrent development of exudative pericardial and pleural effusion arising from the use of valproic acid.

Özet

Valproik asit, birçok nörolojik ve psikiyatrik bozukluğun tedavisinde kullanılan bir ilaçtır. Valproik asit kullanımına bağlı olarak nadiren plevral efüzyon oluşumu görülebilmektedir. İki uçlu bozukluk tanısıyla bir yıldır valproik asit kullanan bir hasta sunmaktayız. Olguda tedavi sırasında plevral ve perikardiyal efüzyon saptanmıştır. Bizim bilgimize göre, valproik asit kullanımı ile ilişkili olarak eş zamanlı perikardiyal ve plevral efüzyon gelişmesinin bildirildiği ilk olgudur.

🔖

Cite This Article

EREN, İ., İNANLI, İ., ETLİ, T., ÖZTÜRK, H. İ. (2022). İki uçlu bozukluğu olan bir hastada valporik asit nedenli perikardiyal ve plevral efüzyon. Klinik Psikofarmakoloji Bülteni, Cilt: 24 - Sayı: 4, 387–390. https://ajindex.com/articles/573992

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Kamenetsky Z, Da’as N, Esayag Y, Kleinman Y, Samuels N. Valproic acid-induced eosinophilic pleural effusion: a case report and review of the literature. Neurologist 2012;18(1):39-40. [CrossRef] 2. Bullington W, Sahn SA, Judson MA. Valproic acid -induced eosinophilic pleural effusion: a case report and review of the literature. Am J Med Sci 2007;333(5):290-2. [CrossRef] 3. Bally C, Martin C, Kraoua S, Kanaan R, Lacronique J, Dusser D, et al. Eosinophilic pleural effusion related to taking valproic acid. Rev Pneumol Clin 2011;67(6):363. [CrossRef] 4. Joshi P, Kasmani R, Hollingsworth J, Fernandes K, Mahajan K. Divalproex sodium induced eosinophilic pleural effusion. Am J Ther 2009;16(6):593-5. [CrossRef] 5. Kravetz JD, Federman DG. Valproic acid -induced eosinophilic pleural effusion. South Med J 2003;96(8):803- 6. [CrossRef] 6. Tryfon S, Saroglou M, Kazanas K, Mermigkis C, Psathakis K, Galanis N. Sodium valproate as a cause of recurrent transudative pleural effusion: a case report. J Med Case Rep 2009;9(6);3:51. 7. André S, Drowart A, De Bels D. Lymphocytic pleural effusion associated with valproic acid. Eur J Intern Med 2005;16(7):535. [CrossRef] 8. Savvas SP, Dimopoulou E, Koskinas J. Valproic acid- associated eosinophilic pleural effusion treated with corticosteroids. Eur J Intern Med 2006;17(1):71. [CrossRef] 9. Catalán Alcántara A, Sánchez Pérez M, Domezain del Campo M, Ruiz Irastorza G. Eosinophilic pleural effusion secondary to treatment with valproic acid. Actas Esp Psiquiatr 2005;33(6):401-2. 10. Fernandez-Perez R, Alvarez-Dobano JM, Suarez-Antelo J, Codesido-Barcala R, Carballal-Calvo F, Arrojo-Romero M, et al. Eosinophilic pleural effusion associated with the addition of sodium valproate. J Clin Psychopharmacol 2009;29(3): 310-1. [CrossRef] 11. Abdelhamid MS, Percival M, Sivakumaran P. Sodium valproate-a rare cause of eosinophilic pleural effusion. Intern Med J 2011;41(11):802-3. [CrossRef] 12. Aluru N, Deak KL, Jenny MJ, Hahn ME. Developmental exposure to valproic acid alters the expression of microRNAs involved in neurodevelopment in zebrafish. Neurotoxicol Teratol 2013;40(6):46-58. [CrossRef] 13. Krenke R, Light RW. Drug-induced eosinophilic pleural effusion. Eur Respir Rev 2011;20(122):300-1. [CrossRef] 14. Markovic J, Momcilov-Popin T, Mitrovic D, Ivanovic- Kovacevic S, Sekuli S, Stojsic-Milosavljevic A. Clozapine- Induced Pericarditis. Afr J Psychiatry 2011;14(3):236-8. [CrossRef] 15. Rubins JB, Rubins HB. Etiology and prognostic signifi